Get the Stockscreener App
29.13
1.02%
-0.30
After Hours:
29.13
Denali Therapeutics Inc stock is traded at $29.13, with a volume of 649.43K.
It is down -1.02% in the last 24 hours and up +19.19% over the past month.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
See More
Previous Close:
$29.43
Open:
$29.12
24h Volume:
649.43K
Relative Volume:
0.64
Market Cap:
$4.17B
Revenue:
$340.81M
Net Income/Loss:
$-145.22M
P/E Ratio:
-26.72
EPS:
-1.09
Net Cash Flow:
$-370.93M
1W Performance:
-3.67%
1M Performance:
+19.19%
6M Performance:
+41.96%
1Y Performance:
+41.20%
1-Day Range:
$28.50
$29.32
1-Week Range:
$28.50
$30.54
52-Week Range:
$14.56
$32.13
Denali Therapeutics Inc Stock (DNLI) Company Profile
Name
Denali Therapeutics Inc
Sector
Industry
Phone
(650) 866-8548
Address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-23 | Initiated | Citigroup | Buy |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Oct-24-23 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-06-23 | Initiated | B. Riley Securities | Buy |
| Jan-30-23 | Initiated | SVB Securities | Outperform |
| Dec-05-22 | Initiated | Cowen | Outperform |
| Nov-02-22 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-02-22 | Initiated | BofA Securities | Buy |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Dec-10-21 | Resumed | Raymond James | Mkt Perform |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-01-21 | Initiated | SMBC Nikko | Outperform |
| May-18-21 | Initiated | UBS | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-10-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-11-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-14-20 | Resumed | JP Morgan | Overweight |
| Aug-20-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-13-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-28-20 | Upgrade | Wedbush | Neutral → Outperform |
| Feb-24-20 | Initiated | Jefferies | Buy |
| Feb-19-20 | Initiated | Stifel | Hold |
| Jan-27-20 | Upgrade | Goldman | Neutral → Buy |
| Sep-26-19 | Initiated | Wedbush | Neutral |
| Sep-13-19 | Initiated | Nomura | Buy |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
| Nov-15-18 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | Janney | Buy |
| Mar-12-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Initiated | Goldman | Neutral |
| Jan-02-18 | Initiated | JP Morgan | Overweight |
| Jan-02-18 | Initiated | Morgan Stanley | Overweight |
View All
Denali Therapeutics Inc Stock (DNLI) Latest News
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Thrivent Financial for Lutherans - MarketBeat
Fred Alger Management LLC Makes New $627,000 Investment in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Point72 Asset Management L.P. Takes $24.45 Million Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Marshall Wace LLP Boosts Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Profund Advisors LLC Sells 39,101 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Ensign Peak Advisors Inc Sells 298,541 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat
Denison Mines stock upgraded by BMO analyst citing attractive P/NPV ratio and strong balance sheet - Investing.com India
Danimer Scientific awarded $1.36 million by DoD - Investing.com India
Denison Mines Corp. - Baystreet.ca
This trade activity should not be overlooked: Denali Therapeutics Inc (DNLI) - SETE News
Denison Mines (NYSEAMERICAN:DNN) Trading Up 5% - Defense World
Hood River Capital Management LLC Has $50.28 Million Stock Holdings in Denison Mines Corp. (NYSEAMERICAN:DNN) - Defense World
Integral Health Asset Management LLC Acquires New Stake in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Danimer Scientific Inc (DNMR Stock: A Sea of Opportunity - The InvestChronicle
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Purchased by American Century Companies Inc. - MarketBeat
State of New Jersey Common Pension Fund D Trims Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Danimer Scientific, Inc. (NYSE:DNMR) Short Interest Down 5.1% in August - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - Kilgore News Herald
(DNLI) On The My Stocks Page - Stock Traders Daily
Denali Therapeutics (NASDAQ:DNLI) Sets New 52-Week High at $31.00 - MarketBeat
Denali Therapeutics director sells $30,600 in company stock - Investing.com India
Denali Therapeutics director sells $30,600 in company stock By Investing.com - Investing.com Canada
Denali Therapeutics director sells $30,600 in company stock - Investing.com
Denali Therapeutics director sells $30,600 in company stock By Investing.com - Investing.com UK
Brokers Issue Forecasts for Denali Therapeutics Inc.'s FY2025 Earnings (NASDAQ:DNLI) - MarketBeat
Rhumbline Advisers Acquires 22,900 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Strength Seen in Denali Therapeutics (DNLI): Can Its 10.1% Jump Turn into More Strength? - Yahoo Finance
ClariVest Asset Management LLC Has $533,000 Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution - Simply Wall St
Denali Therapeutics (NASDAQ:DNLI) Sets New 52-Week High at $25.90 - MarketBeat
Denali Therapeutics stock hits 52-week high at $25.9 - Investing.com
Denali Therapeutics stock hits 52-week high at $25.9 By Investing.com - Investing.com Australia
Denali Therapeutics stock hits 52-week high at $25.9 - Investing.com India
Denali Therapeutics stock hits 52-week high at $25.9 By Investing.com - Investing.com Canada
Denali Therapeutics (NASDAQ:DNLI) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Pier 88 Investment Partners LLC Acquires 29,400 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
FY2025 EPS Estimates for Denali Therapeutics Inc. Cut by Analyst (NASDAQ:DNLI) - MarketBeat
CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics - Yahoo Finance UK
Denali Therapeutics director sells over $77,000 in company stock - Investing.com
BofA rasies Denali Therapeutics share price target, maintains Buy rating - Investing.com
Denali Therapeutics director sells over $77,000 in company stock - Investing.com India
Denali Therapeutics director sells over $77,000 in company stock By Investing.com - Investing.com UK
BofA rasies Denali Therapeutics share price target, maintains Buy rating - Investing.com India
Denali Therapeutics (NASDAQ:DNLI) Given Buy Rating at HC Wainwright - MarketBeat
Bank of America Raises Denali Therapeutics (NASDAQ:DNLI) Price Target to $29.00 - MarketBeat
Stifel holds Denali Therapeutics stock target and rating on FDA path - Investing.com Australia
High-dose Spinraza meets study goal; Top Dyne executives exit - Yahoo Finance
BofA rasies Denali Therapeutics share price target, maintains Buy rating By Investing.com - Investing.com UK
Denali Plans to File for Accelerated Approval of Hunter Syndrome Drug - Yahoo Finance
Denali looks to scale new heights in quest for treatment for rare genetic disorder - The Business Journals
Denali Therapeutics Inc Stock (DNLI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):